Biggest News Aggregation in the World
📰 Rom News

Page 322 - Rom News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Rom. Real-time updates on events, politics, business and more.

BioInvent International: BioInvent Announces Additional Efficacy Data from Intravenous Part of Phase 1/2 Trial with BI-1206 in Solid Tumors

One additional patient has developed a partial response (PR) and one patient has remained on stable disease for over 80 weeksThese long-lasting responses in hard-to-treat metastatic diseases, in patients
Mecklenburg Vorpommern United States Stefan Klotter Cecilia Hofvander Martin Welschof Bioinvent Internationalview

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

FibroGen Announces Topline Results from LELANTOS-1 Phase 3 Clinical Study of Pamrevlumab in Non-Ambulatory Patients with Duchenne Muscular Dystrophy

Study did not meet the primary endpointPamrevlumab was generally safe and well tolerated Topline results from LELANTOS-2 Phase 3 study of pamrevlumab in ambulatory patients with DMD expected 3Q 2023 ... | June 7, 2023
Enrique Conterno Michael Szumera Meichiel Keenan Drug Administration Fibrogen Inc Globenewswire Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science